RxSight (RXST) Change in Receivables (2020 - 2026)
RxSight (RXST) posted Change in Receivables of -$936000.0 for Q1 2026, down 18.78% on a QoQ basis from -$788000.0 in Q4 2025, and down 200.86% year-over-year from $928000.0 in Q1 2025.
RxSight (RXST) Change in Receivables (2020 - 2026) Analysis & Trends
RxSight's Change in Receivables history runs 7 years deep, the most recent figure standing at -$936000.0 for Q1 2026.
- Quarterly Change in Receivables fell 200.86% year-over-year to -$936000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.5 million (down 190.03% YoY) and the FY2025 annual result came in at -$6.7 million, down 167.89% from the prior year.
- Change in Receivables was -$936000.0 for Q1 2026 at RxSight, down from -$788000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $5.0 million in Q4 2023 and bottomed at -$3.9 million in Q3 2025.
- A 5-year average of $1.0 million and a median of $1.3 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables jumped 566.45% — and 2025, when it plunged 1120.94%.
- RxSight's Change in Receivables stood at $1.9 million in 2022, then soared by 160.31% to $5.0 million in 2023, then decreased by 7.05% to $4.7 million in 2024, then slumped by 116.83% to -$788000.0 in 2025, then dropped by 18.78% to -$936000.0 in 2026.
- Business Quant data shows RXST's Change in Receivables at -$936000.0 in Q1 2026, -$788000.0 in Q4 2025, and -$3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | - |
| 10 | RxSight | 224.29 Mn | -193.91 Mn | 23.50 Mn | -936,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -936,000.00 |
| Mar 31, 2026 | -936,000.00 |
| Dec 31, 2025 | -788,000.00 |
| Dec 31, 2025 | -788,000.00 |
| Sep 30, 2025 | -3.91 Mn |
| Sep 30, 2025 | -3.91 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -2.89 Mn |
| Mar 31, 2025 | 928,000.00 |
| Mar 31, 2025 | 928,000.00 |
| Dec 31, 2024 | 4.68 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | -320,000.00 |
| Sep 30, 2024 | -320,000.00 |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Dec 31, 2023 | 5.04 Mn |